RNT

Practice Better Integrates That Clean Life, Further Empowering Health and Wellness Professionals

Retrieved on: 
Tuesday, December 5, 2023
Clinic, Health, Workflow, Practice, RNT, Bachelor of Science, Software, Practice management, RHN, Nursing

TORONTO, Dec. 5, 2023 /PRNewswire/ -- Practice Better, the all-in-one practice management software platform for health and wellness professionals, today announced the integration of That Clean Life, the nutrition planning software acquired earlier this year. For the first time, Practice Better customers can seamlessly consolidate nutrition planning into their workflow from within their practice management platform to give them back time and improve client outcomes.

Key Points: 
  • TORONTO, Dec. 5, 2023 /PRNewswire/ -- Practice Better , the all-in-one practice management software platform for health and wellness professionals, today announced the integration of That Clean Life, the nutrition planning software acquired earlier this year.
  • Practice Better is one of the first practice management platforms to integrate nutrition planning functionality, making it easier for practitioners to provide more holistic care.
  • "Acquiring That Clean Life earlier this year was a significant opportunity for Practice Better.
  • The integration of That Clean Life with Practice Better will be a game changer, not only in my business but in the businesses of countless health practitioners using these platforms."

How to overcome repetitive negative thinking through meditation

Retrieved on: 
Wednesday, July 12, 2023
RNT, Depression, Awareness, Disability, Anxiety, Quality of life, Center, Brain, Emotion, Research, DSM-IV codes, Mindfulness, Thought, Population, Post-traumatic stress disorder, Time, Risk, Happiness, Evaluation apprehension model, Meditation, Efficiency, Health, Mental health, Caregiver burden, Caregiver, Risk management, Design, Nursing, Residential care

Maybe you ruminate on past mistakes, worry excessively about the future, or imagine worst-case scenarios?

Key Points: 
  • Maybe you ruminate on past mistakes, worry excessively about the future, or imagine worst-case scenarios?
  • Many people struggle with repetitive negative thinking, and this can have a serious impact on mental health and well-being.
  • As the coordinator of expertise in caregiving at the Centre for Research and Expertise in Social Gerontology and an associate member of the Centre for Study and Research on India, South Asia and its Diaspora, I would like to shed light on the negative impact of repetitive negative thinking on the mental and physical health of caregivers.

The devastating effects of repetitive negative thinking

    • Repetitive negative thinking (RNT) is a cognitive process characterized by persistent and intrusive contemplation on past events, commonly known as rumination, and apprehensions about future possibilities, often referred to as worries.
    • So, what would be the most effective strategy for managing repetitive negative thinking?
    • Research has demonstrated a negative correlation between RNT and mindfulness, implying that a low level of mindfulness can increase one’s susceptibility to RNT.

Journey to the present: The transformative power of mindfulness

    • There are two main styles of mindfulness practice: focused attention meditation and open monitoring meditation.
    • Focused attention meditation involves choosing a specific object, such as the breath, and bringing your full attention to it.
    • By deactivating the “default mode network,” focused attention meditation can help reduce this harmful type of thinking.

Reducing repetitive negative thinking: A breakthrough for caregivers

    • As part of our project, we will develop and examine an intervention targeted at reducing RNT in family caregivers.
    • Chronic stress is a common experience for family caregivers, and it can take a toll on their health and well-being.
    • A survey of caregivers found that the top areas of need for caregivers were emotional health (58 per cent) and physical health (32 per cent).
    • RNT is strongly associated with caregiver burden and predicts negative impacts on the physical and mental health of caregivers.

Neurent Medical Announces Limited Market Release of NEUROMARK® System to Treat Chronic Rhinitis

Retrieved on: 
Friday, February 3, 2023
Neurology, Medical Devices, Other Health, Health, Health Technology, Nose, AMA, American Medical Association, Swelling, American Academy of Otolaryngology–Head and Neck Surgery, Rhinorrhea, Patient, Inflammation, Otorhinolaryngology, Sneeze, Nasal cavity, Intelligence, CPT, American Academy, RNT, Medicine, Surgeon, PNN, Dentistry

Neurent Medical , a company pioneering innovative non-surgical interventions to treat chronic inflammatory sino-nasal diseases, today announced its NEUROMARK® Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited U.S. markets.

Key Points: 
  • Neurent Medical , a company pioneering innovative non-surgical interventions to treat chronic inflammatory sino-nasal diseases, today announced its NEUROMARK® Rhinitis Neurolysis Therapy (RNT) is now commercially available in limited U.S. markets.
  • Commercialization comes as the American Medical Association (AMA) issued a new Category I Current Procedural Terminology (CPT®) code for posterior nasal nerve ablation (PNN) procedures, which includes NEUROMARK, to treat chronic rhinitis.
  • NEUROMARK’s unique device and intelligent technology platform enable Otolaryngologists to treat chronic rhinitis patients with precision and control and enhance the patient experience from treatment through recovery.
  • The recent endorsement2 of PNN by the AAO-HNS, a specialty society representing almost 12,000 ENT surgeons, further validates Neurent Medical’s long-term future in the treatment of chronic rhinitis.

Rimaunangis SDN BHD Partnership with Sangkara Misa Builds Malaysia's First Agriculture Metaverse

Retrieved on: 
Saturday, July 9, 2022
Crypto, Dato, Non-fungible token, MSA, Livestock, Sale, MISA, PT, World, NFT, First, Farmer, BHD, Tradition, RNT, MOU, Cryptocurrency, Blockchain

Kuala Lumpur, Malaysia--(Newsfile Corp. - July 9, 2022) - Rimaunangis SDN BHD partners with Sangkara Misa to build Malaysia's first agriculture metaverse.

Key Points: 
  • Kuala Lumpur, Malaysia--(Newsfile Corp. - July 9, 2022) - Rimaunangis SDN BHD partners with Sangkara Misa to build Malaysia's first agriculture metaverse.
  • Rimaunangis SDN BHD (RNT) is changing the way the blockchain world is in Malaysia.
  • The CEO of Rimaunangis, Dato' Abdul Haadi Azhar, believes that the financial world will turn digital in the future.
  • MSA CEO, Agustino Wibisono, developer of the Sangkara ($MISA) token said, that this is a merger of Traditional and digital businesses in one unit.

NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

Retrieved on: 
Wednesday, March 9, 2022
Oncology, Medical Devices, Health, Radiology, Pharmaceutical, Biotechnology, Degenerative disease, Cell death, Cornell University, Drug Master File, Company, Prostate, Research, FDA, LLC, Cancer, Waste management, Prostate cancer, RNT, Multimedia, Weill Cornell Medicine, Radioactive decay, Hospital, Radiopharmaceutical, Convergent, Radiation, Patient, RPT, Radionuclide, Technology, NorthStar, Therapy, Google Images, PSMA, Actinium-225, CGMP, Medical imaging, Convergent Therapeutics, Inc., NorthStar Medical Radioisotopes, LLC (NorthStar), CONVERGENT THERAPEUTICS, INC., NORTHSTAR MEDICAL RADIOISOTOPES, LLC (NORTHSTAR)

NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Convergent Therapeutics , Inc., a clinical stage radiopharmaceutical company, today announced the signing of a long-term supply agreement for the therapeutic medical radioisotope, actinium-225 (Ac-225).

Key Points: 
  • NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Convergent Therapeutics , Inc., a clinical stage radiopharmaceutical company, today announced the signing of a long-term supply agreement for the therapeutic medical radioisotope, actinium-225 (Ac-225).
  • Under terms of the agreement, NorthStar will provide Convergent with its environmentally preferred, high purity non-carrier-added (n.c.a.)
  • We are very pleased to enter this Ac-225 supply agreement with Convergent Therapeutics, and we look forward to working with them moving forward.
  • NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that manufactures and distributes diagnostic and therapeutic radiopharmaceuticals.

Neurent Medical Receives FDA Clearance for NEUROMARK™, A Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis

Retrieved on: 
Thursday, November 18, 2021
Medical Devices, Infectious Diseases, FDA, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Patient, Swelling, Safety, Mental health, Technology, Sneeze, Otorhinolaryngology, Inflammation, Food, Physician, Medicine, Rhinorrhea, Food and Drug Administration, FDA, Nose, RNT, Quality of life, Pharmaceutical industry

Neurent Medical , a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced Food and Drug Administration (FDA) clearance of its proprietary NEUROMARK Rhinitis Neurolysis Therapy (RNT).

Key Points: 
  • Neurent Medical , a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced Food and Drug Administration (FDA) clearance of its proprietary NEUROMARK Rhinitis Neurolysis Therapy (RNT).
  • The clearance gives clinicians access to an in-office treatment designed to create lesions to disrupt the posterior nasal nerves, for patients with chronic rhinitis.
  • The truth is, medications, sprays and other intranasal procedures are often either ineffective or only offer short-term relief for patients suffering with chronic rhinitis.
  • NEUROMARK system is a novel multi-point nerve disruption treatment for chronic rhinitis.